Oxford Expression Technologies Launch Innovative Virus Like Particle Expression Vector
Oxford, UK, November 27, 2012 - Oxford Expression Technologies (OET), the award-winning specialist provider of baculovirus-based protein expression solutions, announce the launch of flashBACPRIME, the newest edition to the flashBAC range. The new vector is specifically designed to provide increased virus like particle yield and recovery, and also benefits from the traditional ease of use associated with the renowned flashBAC one step baculovirus expression system.
The new vector offers an innovative solution to one of the challenges of VLP production by providing scientists with enhanced recovery and yield. The performance improvement is achieved by inducing cell lysis at a very late stage of infection in Trichoplusia ni (T.ni) derived cell lines. The flashBACPRIME expression vector also offers flexibility for users, although designed for use in virus like particle production, it can also be used for cytoplasmic protein expression and production.
Passing comment, James Bernard, the CEO at Oxford Expression Technologies said, “We are pleased to announce the launch of flashBACPRIME, it represents a significant improvement in performance and we are delighted to offer these benefits to our customers” he continued, “Yield and recovery are an inherent concern with VLP production and our new technology provides scientists with a solution that addresses these concerns, we are also pleased to add another innovation to our highly successful flashBAC range.”
Oxford Expression Technologies invites anyone with an interest in baculovirus protein expression and virus like particle production to visit their website - http://oetltd.com/
Oxford Expression Technologies is a biotechnology company specializing in the use of baculovirus vectors, a eukaryotic expression system that can express a large variety of recombinant proteins. Oxford Expression Technologies provides recombinant protein expression products, services and consultancy to many global pharmaceutical companies. The Company’s proprietary flashBAC technology enables large amounts of a given protein to be produced in culture. Its internationally renowned expertise and products enable proteins to be produced faster, more easily and cost-effectively using automated and high-throughput methods compared with other baculovirus expression systems. This contributes to the development of new drugs and research targeted towards understanding how proteins work in health and disease.
The company was founded in 2007 as a result of collaboration between Oxford Brookes University and the Natural Environment Research Council to provide researchers with custom proteins for research purposes.
For Further information or an illustrative image:
Media contact - Mathew Taylor, Director, Algorythm Solutions Ltd, mobile: +44 (0)773 403 2112, email: email@example.com, website: www.algorythmsolutions.com
Algorythm Solutions Ltd
10 Torkington St
Stamford, Lincolnshire PE9 2UY
+44 (0)773 403 2112
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oxford Expression Technologies Launch Innovative Virus Like Particle Expression Vector here
News-ID: 244621 • Views: 2136
More Releases from Algorythm Solutions Ltd
Axicon Labels to Launch New Labelling Service at Foodex 2014
Axicon Labels, part of the Axicon Group, will launch a new ‘print your own’ labelling service at Foodex food and drink expo, 24-26 March at the NEC in Birmingham. Oxford, UK, January 27, 2014 - Axicon Labels, part of the Axicon Group, will launch a new ‘print your own’ labelling service at Foodex food and drink expo, 24-26 March at the NEC in Birmingham. Foodex is the UK trade show for
Axicon Labels Offer Premium Service for Food Importers
Axicon labels, part of the Axicon Auto ID group, launch a premium service to the food import sector. Oxford, UK, November 26, 2013 - Axicon labels, part of the Axicon Auto ID group, launch a premium service to the food import sector. Coverall labels are required on many imported products to comply to stringent EU guidelines on nutritional information, additives, Genetically Modified Organisms (GMO'S) as well as allergens and can
Axicon Auto ID Launch New On-line Barcode Validation System
Axicon Auto ID Ltd, a world leader in barcode verification, announce the launch of a new online barcode validation system. Oxford, UK, November 05, 2013 - Axicon Auto ID Ltd, (Oxford, UK) a world leader in barcode verification, announce the launch of a new online barcode validation system. The Checkrite 5 is a stand alone, on-line barcode validation system that can be used in conjunction with a range of different barcode readers.
Axicon Auto ID Build Online Video Training Resource
Axicon Auto ID Ltd, (Oxford, UK) a world leader in barcode verification, continue to develop their online video training resource. Oxford, UK, September 12, 2013 - Axicon Auto ID Ltd, (Oxford, UK) a world leader in barcode verification, continue to develop their online video training resource. The company recently added a new video to compliment the launch of their new Industrial Protection Range (IP), the video is a full product demonstration
More Releases for Oxford
FISH Probe Market - Regional Production Development 2025 | Oxford Gene Technolog …
FISH Probe Market: Snapshot The technique fluorescence in situ hybridization (FISH) is extensively used by cytogeneticists world over for making fluorescent DNA probes with the aim of detecting a range of chromosomal abnormalities in patients. FISH probes have wide applications in cancer cytogenetics as they expand our understanding of hematopoietic and non-hematopoietic malignancies. Globally, the areas of biomarker research and personalized medicines have been witnessing rapid advances from the application of
NHS Dentist Oxford – Damira Dental
Damira Dental Bury Knowle is an excellent NHS Dentist in Oxford dedicated to providing exceptional levels of NHS dental care. Established in 2003, Damira Dental Studios has grown from this one small practice in Oxford to a leading provider of high quality dentistry across Southern England. Damira Dental now comprises 18 practices across London, Hampshire and Oxfordshire! They offer a comprehensive range of treatments both through the NHS and privately
Oxford Instruments awarded Best Technology Company 2012
Oxford Instruments plc, a leading provider of high technology tools and systems for research and industry, has won the award for Best Technology Company 2012 at the annual PLC Awards. The awards, sponsored by Price Waterhouse Coopers, reward excellence amongst the smaller companies quoted on the London Stock Exchange. Attracting more than 1,500 guests, including quoted companies, investment banks, fund managers, investment analysts and corporate advisors, the awards are 'the' City
Oxford Gene Technology and Abcodia form Partnership
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced a collaborative agreement with Abcodia, a specialist company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases, aimed at improving the early detection of pancreatic cancer. As part of this collaboration, Abcodia will provide access to its large prospective serum biobank, to harness samples taken from
Oxford Instruments plc enters the FTSE 250
The FTSE Group has announced that Oxford Instruments plc, the leading provider of high technology tools and systems for industry and research, has been promoted to the FTSE 250 index. Jonathan Flint, Chief Executive, says “Joining the FTSE 250 is an outstanding milestone for Oxford Instruments and something all our employees can be extremely proud of. It reflects the huge steps forward the Group has made during recent times, successfully
Oxford Gene Technology releases new white paper
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has released a new white paper discussing the relative merits of DNA microarrays and next generation sequencing (NGS) for human genome analysis. Although the development of genome analysis technologies such as DNA microarrays and NGS has provided the researcher with the unique ability to screen for sequence variants of clinical relevance, each technology has